Why Is Xeris Biopharma ( $XERS) Stock Up +13.53% Today? The rally is a follow-through on Thursday's Q3 results, where Recorlev revenue surged +93% and the compa

Why Is Xeris Biopharma ( $XERS) Stock Up +13.53% Today? The rally is a follow-through on Thursday's Q3 results, where Recorlev revenue surged +93% and the company beat estimates while raising full-year 2026 guidance to $395M-$405M and lifting its 2030 revenue target above $1 billion.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp 🔗 Copy Link

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

---

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly